Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-13

FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a generic norepinephrine bitartrate injection under an original ANDA from Rising Pharma Holdings, Inc. for use in the management of acute hypotensi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norepinephrine bitartrate (Norepinephrine bitartrate)

Snippet

ORIG AP for NOREPINEPHRINE BITARTRATE (NOREPINEPHRINE BITARTRATE)